Sponsor

Elpen Pharmaceutical Co. Inc.

Clinical research sponsor

Published trials26
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

26 shown
Administration of Fingolimod in Greek Patients With Multiple Sclerosis.NCT06949956 · lead sponsor · 2025-06-01
NOT_YET_RECRUITING
TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.NCT06117722 · lead sponsor · 2024-03-06
UNKNOWN
QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.NCT06170125 · lead sponsor · 2024-03-01
UNKNOWN
Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.NCT05426915 · lead sponsor · 2023-05-01
UNKNOWN
AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.NCT04835961 · lead sponsor · 2021-05-01
COMPLETED
Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart FailureNCT03947853 · lead sponsor · 2019-10-01
WITHDRAWN
A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) CombinationNCT03858348 · lead sponsor · 2019-05-01
COMPLETED
COMPLliancE and qualiTy of lifE in AsthmaNCT03300076 · lead sponsor · 2018-02-01
COMPLETED
Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial HypertensionNCT03139084 · lead sponsor · 2017-12-01
WITHDRAWN
AdHerencE to Treatment and quAlity of Life in COPDNCT03299673 · lead sponsor · 2017-12-01
COMPLETED
Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical PracticeNCT03055793 · lead sponsor · 2017-03-01
COMPLETED
Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.NCT03033758 · lead sponsor · 2017-02-02
COMPLETED
EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in GreeceNCT02978703 · lead sponsor · 2017-01-01
COMPLETED
Bosentan Treatment of Digital Ulcers Related to Systemic SclerosisNCT02798055 · lead sponsor · 2016-09-30
COMPLETED
Eplerenone in Heart Failure TreatmentNCT02344199 · lead sponsor · 2015-03-01
COMPLETED
Clinical Trial in Patients With Hypertension and Left Ventricular DysfunctionNCT02148991 · lead sponsor · 2014-07-01
COMPLETED
Multiple Electrode Aggregometry & Clopidogrel ResistanceNCT01991093 · lead sponsor · 2014-06-01
COMPLETED
eVAluatIon of OLanzapine TreatmEnTNCT02006862 · lead sponsor · 2014-01-01
COMPLETED
A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.NCT01855659 · lead sponsor · 2013-06-01
COMPLETED
Prospective evAluatIon foR Inhalation Devices StudyNCT01800994 · lead sponsor · 2013-02-01
COMPLETED
BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) StudyNCT01708486 · lead sponsor · 2013-02-01
COMPLETED
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticENCT01772095 · lead sponsor · 2013-02-01
COMPLETED
ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)NCT01475045 · lead sponsor · 2011-01-01
COMPLETED
Carvedilol Vascular Efficacy TrialNCT01484327 · lead sponsor · 2009-01-01
COMPLETED
Efficacy and Safety Study of Fluticasone/Salmeterol Administered With ElpenhalerNCT05459194 · lead sponsor · 2008-10-01
COMPLETED
Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®NCT01484210 · lead sponsor · 2008-03-01
COMPLETED

Sponsor roles

lead sponsor26

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.